The store will not work correctly when cookies are disabled.
4-(4-((quinolin-8-yloxy)methyl)-1H-1,2,3-triazol-1-yl)benzenesulfonamide
ID: ALA4760913
PubChem CID: 162657636
Max Phase: Preclinical
Molecular Formula: C18H15N5O3S
Molecular Weight: 381.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NS(=O)(=O)c1ccc(-n2cc(COc3cccc4cccnc34)nn2)cc1
Standard InChI: InChI=1S/C18H15N5O3S/c19-27(24,25)16-8-6-15(7-9-16)23-11-14(21-22-23)12-26-17-5-1-3-13-4-2-10-20-18(13)17/h1-11H,12H2,(H2,19,24,25)
Standard InChI Key: WYMTWUUEOSGFOW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
30.7449 -11.9246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4615 -12.3371 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.4604 -11.5102 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1352 -18.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1340 -19.5767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8488 -19.9896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8470 -18.3366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5624 -18.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5632 -19.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2784 -19.9835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9935 -19.5687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9886 -18.7388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2728 -18.3317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8446 -17.5116 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1288 -17.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1264 -16.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7918 -15.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5346 -15.0092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7095 -15.0116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4571 -15.7970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0139 -14.3431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8355 -14.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3183 -13.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9805 -13.0067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1553 -12.9251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6762 -13.5941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2834 -12.4199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
7 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
20 16 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
18 21 1 0
24 2 1 0
2 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 381.42 | Molecular Weight (Monoisotopic): 381.0896 | AlogP: 2.04 | #Rotatable Bonds: 5 |
Polar Surface Area: 112.99 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.56 | CX Basic pKa: 2.85 | CX LogP: 2.09 | CX LogD: 2.09 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.57 | Np Likeness Score: -2.03 |